viewAlliance Pharma PLC

Alliance Pharma on target to meet market expectations after a solid first-half

Revenues were up 10% in the first six months of the year as the company's star brands performed strongly

Vanousse advert
Vamousse, a head lice treatment, is one of the company's international star brands

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical group, said it is trading in line with expectations.

In an update, it said revenues for the six months ended June 30 rose 10% to £54.4mln, though trading profit tracked at a slightly slower pace due largely to the phasing of marketing spend.

The company’s star international brands MacuShield, Vamousse and Kelo-Cote delivered “strong performances”, investors were told. The latter, a treatment for scarring, saw its sales increase 77% to almost £11mln.

Revenues from what Alliance calls local hero brands were in line with forecasts.

Cash flow remained strong

The company said its top line was negatively affected by currency fluctuations to the tune of £900,000.

Underlying free cash flow was £10.1mln, while net debt increased by £14mln to £86.3mln as it funded acquisitions such as the purchase of medicated anti-dandruff shampoo, Nizoral.

The company said it expects to launch anti-nausea treatment Xonvea in the UK in the autumn.

“On the basis of trading in the year to date, the board expects revenue and underlying profit before tax for the current financial year to be in line with expectations,” the market was told.

Quick facts: Alliance Pharma PLC

Price: 73.28 GBX

Market: AIM
Market Cap: £388.69 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Alliance Pharma PLC named herein, including the promotion by the Company of Alliance Pharma PLC in any Content on the Site, the Company...


2 min read